750 likes | 880 Vues
This resource explores strategies to enhance cancer risk assessment and testing for Lynch syndrome in gastroenterology. It discusses the prevalence of mutations and high cancer risks associated with Lynch syndrome, emphasizing the importance of family history assessment. A standardized approach to risk assessment is presented, alongside the PREMM1,2,6 clinical prediction model which estimates gene-specific risk. The document also reviews genetic testing results and survey findings from patients and providers, highlighting the clinical benefits of proactive screening for Lynch syndrome-related cancers.
E N D
Hereditary Cancer Risk Assessment and Testing: Strategies to Optimize Outcomes in Today’s Gastroenterology Practice
A Standardized Approach to Risk Assessment for Lynch Syndrome
Example of a Clinical Prediction Model to Assess for Lynch Syndrome: PREMM1,2,6
PREMM1,2,6 Model Estimates Gene-Specific Risk in Lynch Syndrome
Hereditary Cancer Risk Assessment in Today’s Busy GI Practice:Why & How We Do It
Clinical and Practice Benefits of Screening and Testing for Lynch Syndrome-related Cancer